CIRCULATING BIOMARKERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140141986A1
SERIAL NO

14001016

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease. Circulating biomarkers can be detected and optionally used in profiling of physiological states or determining phenotypes. These include nucleic acids, protein, and circulating structures such as vesicles. Biomarkers can be assessed for diagnostic, prognostic or theranostic purposes, e.g., to select candidate treatment regimens for diseases, conditions, disease stages, and stages of a condition, and can also be used to determine treatment efficacy. Examples of useful circulating biomarkers include polypeptides, nucleic acids (e.g., DNA, mRNA, microRNA) and vesicles.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS S A R L102 RUE DE MARAICHERS L2124 GRAND-DUCHE DE LUXEMBOURG LUXEMBOURG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Holterman, Daniel A Phoenix, US 1 46
Pawlowski, Traci Laguna Niguel, US 49 549
Spetzler, David Paradise Valley, US 58 594
Tasinato, Andrea Gimel, CH 2 93

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation